Surgical-Clinical Correlation in Unilateral Conductive Hearing Loss With Intact Tympanic Membrane

Recruiting N/A Interventional Study
Conductive Hearing Loss, Unilateral
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Al-Azhar University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Unilateral conductive hearing loss (UCHL) in the presence of an intact tympanic membrane represents a diagnostic challenge in otologic practice. In the absence of middle ear effusion or tympanic membrane pathology, stapes fixation secondary to otosclerosis is often considered the most probable diagnosis. However, although otosclerosis is traditionally regarded as a bilateral disease, clinical pres…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * unilateral conductive hearing loss or mixed HL with intact Tympanic Membrane * Average Airborne Gap Above 20 decibels Exclusion Criteria * Sensorineural hearing loss * Chronic otitis media * TM perforation * Previous ear surgery
Contacts

tarek Mansour, head of research committe

+0201006237731

ethicscommitt0ee@azhar.edu.eg

CONTACT